nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—FGFR4—renal system—ureter cancer	0.0573	0.0642	CbGeAlD
Ponatinib—FGFR4—kidney—ureter cancer	0.0554	0.0621	CbGeAlD
Ponatinib—FGFR3—renal system—ureter cancer	0.0391	0.0438	CbGeAlD
Ponatinib—FGFR3—urethra—ureter cancer	0.0384	0.0431	CbGeAlD
Ponatinib—FGFR3—kidney—ureter cancer	0.0378	0.0424	CbGeAlD
Ponatinib—BCR—renal system—ureter cancer	0.0338	0.0379	CbGeAlD
Ponatinib—BCR—urethra—ureter cancer	0.0332	0.0373	CbGeAlD
Ponatinib—FGFR1—urethra—ureter cancer	0.0296	0.0331	CbGeAlD
Ponatinib—CYP3A4—urine—ureter cancer	0.0278	0.0311	CbGeAlD
Ponatinib—CYP2D6—urine—ureter cancer	0.0273	0.0306	CbGeAlD
Ponatinib—SRC—Netrin mediated repulsion signals—DCC—ureter cancer	0.0273	0.252	CbGpPWpGaD
Ponatinib—RET—renal system—ureter cancer	0.0269	0.0302	CbGeAlD
Ponatinib—LCK—urethra—ureter cancer	0.0265	0.0297	CbGeAlD
Ponatinib—RET—kidney—ureter cancer	0.026	0.0292	CbGeAlD
Ponatinib—FGFR2—renal system—ureter cancer	0.0256	0.0287	CbGeAlD
Ponatinib—FGFR2—kidney—ureter cancer	0.0247	0.0277	CbGeAlD
Ponatinib—TEK—renal system—ureter cancer	0.0245	0.0275	CbGeAlD
Ponatinib—TEK—urethra—ureter cancer	0.0241	0.027	CbGeAlD
Ponatinib—TEK—kidney—ureter cancer	0.0237	0.0266	CbGeAlD
Ponatinib—PDGFRA—renal system—ureter cancer	0.0222	0.0249	CbGeAlD
Ponatinib—SRC—renal system—ureter cancer	0.0218	0.0244	CbGeAlD
Ponatinib—SRC—kidney—ureter cancer	0.0211	0.0236	CbGeAlD
Ponatinib—SRC—DCC mediated attractive signaling—DCC—ureter cancer	0.0208	0.193	CbGpPWpGaD
Ponatinib—KDR—renal system—ureter cancer	0.02	0.0225	CbGeAlD
Ponatinib—KDR—urethra—ureter cancer	0.0197	0.0221	CbGeAlD
Ponatinib—KDR—kidney—ureter cancer	0.0194	0.0217	CbGeAlD
Ponatinib—KIT—renal system—ureter cancer	0.0178	0.0199	CbGeAlD
Ponatinib—KIT—urethra—ureter cancer	0.0175	0.0196	CbGeAlD
Ponatinib—KIT—kidney—ureter cancer	0.0172	0.0193	CbGeAlD
Ponatinib—ABL1—renal system—ureter cancer	0.0155	0.0173	CbGeAlD
Ponatinib—ABL1—urethra—ureter cancer	0.0152	0.017	CbGeAlD
Ponatinib—ABL1—kidney—ureter cancer	0.015	0.0168	CbGeAlD
Ponatinib—SRC—Netrin-mediated signaling events—DCC—ureter cancer	0.0108	0.0994	CbGpPWpGaD
Ponatinib—CYP2C8—renal system—ureter cancer	0.01	0.0112	CbGeAlD
Ponatinib—CYP2C8—kidney—ureter cancer	0.0097	0.0109	CbGeAlD
Ponatinib—ABCG2—urethra—ureter cancer	0.00958	0.0107	CbGeAlD
Ponatinib—CYP3A5—renal system—ureter cancer	0.00905	0.0102	CbGeAlD
Ponatinib—CYP3A5—kidney—ureter cancer	0.00875	0.00982	CbGeAlD
Ponatinib—SRC—Netrin-1 signaling—DCC—ureter cancer	0.00865	0.0799	CbGpPWpGaD
Ponatinib—CYP3A4—renal system—ureter cancer	0.00679	0.00762	CbGeAlD
Ponatinib—CYP2D6—renal system—ureter cancer	0.00669	0.0075	CbGeAlD
Ponatinib—CYP3A4—kidney—ureter cancer	0.00657	0.00737	CbGeAlD
Ponatinib—CYP2D6—kidney—ureter cancer	0.00646	0.00725	CbGeAlD
Ponatinib—ABCB1—renal system—ureter cancer	0.00481	0.00539	CbGeAlD
Ponatinib—ABCB1—urethra—ureter cancer	0.00472	0.0053	CbGeAlD
Ponatinib—ABCB1—kidney—ureter cancer	0.00465	0.00521	CbGeAlD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00403	0.0373	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00402	0.0372	CbGpPWpGaD
Ponatinib—KDR—Axon guidance—DCC—ureter cancer	0.00359	0.0332	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00353	0.0326	CbGpPWpGaD
Ponatinib—SRC—Cell-Cell communication—DCC—ureter cancer	0.0035	0.0324	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—DCC—ureter cancer	0.00264	0.0244	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00258	0.0238	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—DCC—ureter cancer	0.00256	0.0237	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—DCC—ureter cancer	0.00233	0.0215	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—DCC—ureter cancer	0.00231	0.0214	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—DCC—ureter cancer	0.00189	0.0174	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—DCC—ureter cancer	0.00169	0.0156	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—DCC—ureter cancer	0.00166	0.0153	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—DCC—ureter cancer	0.00165	0.0153	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00152	0.0141	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—DCC—ureter cancer	0.0012	0.0111	CbGpPWpGaD
